000			02039 a2200541 4500
005			20250513191553.0
264		0	_c19990914
008			199909s 0 0 eng d
022			_a0022-3042
024	7		_a10.1046/j.1471-4159.1999.0731058.x _2doi
040			_aNLM _beng _cNLM
100	1		_aRawls, S M
245	0	0	_aPresynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. _h[electronic resource]
260			_bJournal of neurochemistry _cSep 1999
300			_a1058-65 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a4-Aminopyridine _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCalcium _xphysiology
650	0	4	_aChelating Agents _xpharmacology
650	0	4	_aDicarboxylic Acids _xpharmacology
650	0	4	_aEgtazic Acid _xpharmacology
650	0	4	_aEnkephalin, D-Penicillamine (2,5)-
650	0	4	_aEnkephalins _xpharmacology
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMuscarinic Agonists _xpharmacology
650	0	4	_aMuscarinic Antagonists _xpharmacology
650	0	4	_aNaltrexone _xanalogs & derivatives
650	0	4	_aNarcotic Antagonists _xpharmacology
650	0	4	_aNeostriatum _xdrug effects
650	0	4	_aNerve Endings _xdrug effects
650	0	4	_aNeurotransmitter Uptake Inhibitors _xpharmacology
650	0	4	_aPotassium Channel Blockers
650	0	4	_aPotassium Channels _xmetabolism
650	0	4	_aPyrrolidines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Muscarinic _xdrug effects
650	0	4	_aReceptors, Opioid, kappa _xdrug effects
650	0	4	_aReceptors, Presynaptic _xdrug effects
650	0	4	_aSynaptosomes _xdrug effects
700	1		_aMcGinty, J F
700	1		_aTerrian, D M
773	0		_tJournal of neurochemistry _gvol. 73 _gno. 3 _gp. 1058-65
856	4	0	_uhttps://doi.org/10.1046/j.1471-4159.1999.0731058.x _zAvailable from publisher's website
999			_c10419469 _d10419469